| Name | Title | Contact Details |
|---|
Hoja is a business center dedicated in offering a bundle of services to businesses and individuals. Our offices are located in the capital city of Kosova in Prishtina. We aim to build and offer a bundle of services to businesses and individuals by delivering value and high quality solutions. Our commitment ranges from the beginning of a collaboration, to the extensive needs that follow through our partnerships. We must provide value, both for our company and our clients. We must meet or exceed all requirements in an efficient and cost effective manner. We must maintain a balance of proven techniques with the ability to be innovative . Our markets will include industrial, commercial, agricultural, regional and residential clients. Our company will be able to provide a package of services that will allow us to offer conception to completion efficiency.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Stillwater Insurance Group is a national insurance provider offering a full suite of insurance products and services. We strive to be the most respected insurance provider in the United States by setting and achieving the highest standards in quality products, service, customer experience and claims satisfaction. Stillwater is: Smart - we meet the evolving needs for homeowners, auto and business insurance Fast - We exceed expectations for customer and claims service Strong - Were ready when needed to help our customers get back on their feet We have an A+ accreditation from the Better Business Bureau. This recognizes our commitment to transparency, responsiveness, integrity and delivering on the promises we make. And we have an A- (Excellent) rating from A.M. Best, the leading insurance rating organization.
EverZinc is a global leader in producing specialty zinc materials, with a history of over 185 years. Established in 2016, the company became the worlds largest zinc specialty chemical producer after merging with U.S. Zinc in 2022. Headquartered in Houston, Texas, EverZinc operates 14 production sites across North America, Europe, and Asia, employing over 800 people. The company specializes in four main product lines: fine zinc powders, zinc oxide, zinc powders for batteries, and Zano®, an ultra-fine zinc oxide. These products serve various industries, including personal care, pharmaceuticals, chemicals, textiles, agriculture, paints, coatings, and rubber. EverZincs advanced manufacturing technologies and focus on material science support its diverse customer base and contribute to its strong growth in the zinc specialty chemical market.